Significant Increase in Adjusted EBITDA
Generated $6.8 million in adjusted EBITDA, a 111% increase over the previous year.
Substantial Improvement in Free Cash Flow
Achieved $10.3 million in year-to-date free cash flow, a 328% improvement over 2023.
Repayment of Credit Line
Fully paid down a $10 million credit line, demonstrating strong financial management.
Resumption of Dividends
On track to resume monthly dividend payments on Series A and Series B preferred shares starting in March 2025.
AI Developments
Advancements in CareCloud CirrusAI, including integration with EHR systems and new features like claim note summarization, saving users approximately 70% of time.
Successful Cost Reductions
Progress in cost-cutting initiatives, with $26 million identified in potential expense cuts.